Orsight Pharma is at the forefront of developing an innovative drug for Neovascular Age-Related Macular Degeneration (nAMD or wet AMD), an advanced form of eye disease that is the leading cause of severe vision loss and blindness in developed countries. Our mission is to improve nAMD patients’ anatomical and visual outcome as well as their quality of life.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Wadi El-Haj, 13,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- & Development Yissum.
- HQ
- Nazareth
Orsight Pharma Ltd Questions
Orsight Pharma Ltd's LinkedIn profile is https://il.linkedin.com/company/orsight-pharma
Orsight Pharma Ltd has
2 employees.
View email and phone details for 2
employees at Orsight Pharma Ltd.
Orsight Pharma Ltd's industry is
Biotechnology Research
Orsight Pharma Ltd's top competitors are
Critical Future,
Biomed Israel 2025,
Ub Therapeutics,
Evogene,
Nurexone Biologic (Otcqb:nrxbf) (Tsxv: Nrx) (Fse: J90),
Ngt,
Minovia Therapeutics,
Pre-Cure,
Pluri,
Emris Pharma.
Orsight Pharma Ltd's categories are Biotechnology Research
Orsight Pharma Ltd's founding year is 2024
